Clinical Trial Update: Optimization of Keverprazan-amoxicilli Dual Therapy for Helicobacter Pylori [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating optimization of Keverprazan-amoxicillin dual therapy for Helicobacter pylori infection. The study is currently not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• AMOXICILLIN (AMOXICILLIN)
• Keverprazan

Snippet

Sponsor: Nanjing First Hospital, Nanjing Medical University | Conditions: H. Pylori Infection | Phase 4 | Status: NOT_YET_RECRUITING